Clinical Trial Update: GPC3/Mesothelin-CAR-γδT Cells Against Cancers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating GPC3/Mesothelin-CAR-γδT cells for pancreatic, lung, liver cancers and mesothelioma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer
• Lung Cancer
• Mesothelioma
• Pancreatic Cancer

Drugs mentioned

• GPC3/Mesothelin-CAR-γδT cells

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Pancreas Cancer, Lung Cancer | Phase 1 | Status: RECRUITING